 |
|
|
|
|
|
 Introduction
Human
Veterinary
Environmental
Industrial
Agricultural
MSG
Introduction
Medical
Veterinary
Environmental
Industrial
Agricultural
Introduction
Susceptibility
MIC Database
Procedures
Histopathology
Introduction
Abbreviations
Links
CME
Conference
Highlights
Bibliography
Glossary
Good Books
Events Calendar
Introduction
Our Mission
Editorial Board
Editorial Staff
Supporters
Contributors
Legal Stuff
Privacy Policy
Kudos
Introduction
Descriptions
Synonyms
Image Bank
Lecture Bank
Video Bank
This page updated:
1/27/2007 9:23:00 AM
DoctorFungus - All Rights Reserved
© 2007 Copyright
& Privacy Policy
Site built and designed for doctorfungus by Webillustrated
|
 |
 |
|
|
You are here:
The Fungi
> Descriptions >
|
Madurella spp.
(described by Brumpt in 1905)
|  |
Kingdom: Fungi
Phylum: Ascomycota
Class: Euascomycetes
Order: Dothideales
Family: Lophiostomataceae
Genus: Madurella
Madurella is a dematiaceous (phaeoid, or dark-walled) filamentous fungus found in soil, particularly in tropical and subtropical areas of Africa, India, and South America. The members of this genus don't have any known teleomorphs. Madurella is pathogenic for humans and causes infections.
The genus Madurella has two species; Madurella mycetomatis and Madurella grisea. See the summary of synonyms for the Madurella spp.
Madurella spp. are among the causative agents of human mycetoma. Strains belonging to this genus are isolated specifically from cases with black-grain eumycetoma. The fungus enters the human body via trauma and the progression of mycetoma is very slow which may take several years. Mycetoma remains localized and involves the cutaneous and subcutaneous tissues, the fascia, and the bones. Tumefaction and draining sinuses are typical [1486].
Madurella colonies grow slowly. Madurella mycetomatis grows well at 37°C while Madurella grisea grows poorly or does not grow at all at this temperature.The texture of the colonies is glabrous to wooly. They are raised to heaped and sometimes radially folded. From the front, the color varies from white to yellow-brown, dark gray or olive brown. From the reverse, it is dark brown. Occasionally, a brownish diffusible pigment may also be produced [531, 1295, 2144].
Septate hyphae, chlamydospores, and sclerotia (large and black masses of hyphae) are observed. Madurella strains are dematiaceous and sterile under laboratory conditions. However, occasional isolates of Madurella mycetomatis may form phialides having collarettes in the laboratory. These phialides bear round or oval conidia at their tips [531, 1295, 2144].
Phaeoid granules composed of hyphae are observed. See our histopathology page.
No special precautions other than general laboratory precautions are required.
Very limited data are available. In a previous in vitro assay, ketoconazole and itraconazole MICs appeared to be lower than those of econazole and miconazole [2313]. In a more recent study, voriconazole
MICs were found to be considerably low, while those of itraconazole were variable [1864].
For MICs of various antifungal drugs for Madurella, see our susceptibility database.
A combination of antifungal and surgical therapy is usually preferred for treatment of cases with mycetoma. Ketoconazole yields favorable response rates when used for polonged durations of as long as 8 to 24 months. Griseofulvin may be used in patients who do not respond to ketoconazole [1413, 1486, 2312].
PubMed
GenBank
|
|
References
531. de Hoog, G. S., J. Guarro, J. Gene, and M. J. Figueras. 2000. Atlas of Clinical Fungi, 2nd ed, vol. 1. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands.
1295. Larone, D. H. 1995. Medically Important Fungi - A Guide to Identification, 3rd ed. ASM Press, Washington, D.C.
1413. Mahgoub, E. S., and S. A. Gumaa. 1984. Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii. Trans R Soc Trop Med Hyg. 78:376-9.
1486. McGinnis, M. R. 1996. Mycetoma. Dermatol Clin. 14:97-104.
1864. Radford, S. A., E. M. Johnson, and D. W. Warnock. 1997. In vitro studies of activity of voriconazole (UK-104,496), a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrob. Agents Chemother. 41:841-843.
2144. St-Germain, G., and R. Summerbell. 1996. Identifying Filamentous Fungi - A Clinical Laboratory Handbook, 1st ed. Star Publishing Company, Belmont, California.
2312. Venugopal, P. V., and T. V. Venugopal. 1993. Treatment of eumycetoma with ketoconazole. Australas J Dermatol. 34:27-9.
2313. Venugopal, P. V., T. V. Venugopal, E. S. Ramakrishna, and S. Ilavarasi. 1993. Antimycotic susceptibility testing of agents of black grain eumycetoma. J Med Vet Mycol. 31:161-4.
|
|
|
 |
 |
Home |
Image Bank |
Lecture Bank |
Knowledgebase |
Site Map |
Contact Us |
The Fungi |
Mycoses |
Drugs |
Laboratory |
Education & Tools |
About Us
|
|
|
|